What is the likely diagnosis and recommended work‑up for a patient with alkaline phosphatase 21 IU/L, hematocrit 35.8 %, hemoglobin 11.7 g/dL, serum iron 272 µg/dL, mean corpuscular hemoglobin 26.8 pg, mean corpuscular hemoglobin concentration 32.6 g/dL, and red‑cell distribution width 16.6 %?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Likely Diagnosis: Iron Overload or Hemochromatosis

This patient requires immediate evaluation for iron overload, specifically hemochromatosis, given the markedly elevated serum iron (272 µg/dL) combined with low alkaline phosphatase (21 IU/L), anemia with elevated RDW (16.6%), and microcytic indices (MCH 26.8 pg, MCHC 32.6 g/dL).

Laboratory Interpretation

The constellation of findings presents two distinct abnormalities requiring parallel investigation:

Iron Overload Pattern

  • Serum iron of 272 µg/dL is significantly elevated (normal range typically 60-170 µg/dL)
  • This level suggests either hemochromatosis or secondary iron overload
  • The presence of anemia (Hgb 11.7 g/dL, HCT 35.8%) with high iron is paradoxical and highly concerning 1

Low Alkaline Phosphatase

  • ALP of 21 IU/L is markedly low (normal range typically 40-130 IU/L)
  • Persistently low ALP (<40 IU/L) occurs in only 0.01% of tested populations 2
  • This raises suspicion for hypophosphatasia, though it can also occur with severe malnutrition, hypothyroidism, or zinc deficiency 3

Anemia with Elevated RDW

  • The microcytic indices (MCH 26.8, MCHC 32.6) with elevated RDW (16.6%) suggest either:
    • Combined iron deficiency despite high serum iron (functional iron deficiency)
    • Thalassemia trait
    • Anemia of chronic disease 4

Critical Pitfall

The high serum iron does NOT exclude iron deficiency. In hemochromatosis, patients can paradoxically have anemia with elevated iron levels due to inability to utilize iron properly 1. The elevated RDW with microcytic indices strongly suggests iron-restricted erythropoiesis despite iron overload 5.

Recommended Work-Up (Priority Order)

Immediate Testing (Within 1 Week)

  1. Iron studies panel:

    • Serum ferritin (most powerful test for iron status) 6
    • Transferrin saturation (TfS)
    • Total iron-binding capacity (TIBC)
    • Target: Ferritin >100 µg/L essentially excludes iron deficiency; <30 µg/L confirms it 4, 6
  2. Hemochromatosis evaluation:

    • HFE gene testing (C282Y and H63D mutations) 7
    • If transferrin saturation >45%, hemochromatosis is highly likely 7
  3. Bone-specific alkaline phosphatase:

    • Total ALP can be normal in hypophosphatasia while bone-specific ALP is low 8
    • This distinguishes bone disease from other causes of low ALP
  4. Complete metabolic panel:

    • Liver function tests (AST, ALT, bilirubin)
    • Kidney function (creatinine, BUN)
    • Thyroid function (TSH)
    • Zinc and copper levels

Secondary Testing (Within 2-4 Weeks)

  1. Reticulocyte count:

    • Low/normal reticulocytes indicate inadequate bone marrow response 9, 5
    • High reticulocytes suggest hemolysis or blood loss
  2. Hemoglobin electrophoresis:

    • Rule out thalassemia trait (common cause of microcytosis with normal/high iron) 6
    • Particularly important given microcytic indices
  3. Vitamin B12 and folate:

    • Combined deficiency can mask microcytosis and cause elevated RDW 4
  4. If bone-specific ALP is low:

    • Pyridoxal-5-phosphate (vitamin B6) - elevated in hypophosphatasia 3, 10
    • Phosphoethanolamine (urine)
    • ALPL gene sequencing if clinical suspicion remains high 3

Conditional Testing

  1. If ferritin >1000 ng/mL or transferrin saturation >45%:

    • Liver biopsy for hepatic iron concentration and fibrosis staging 7
    • Cardiac MRI if symptomatic (cardiomyopathy risk)
  2. If gastrointestinal symptoms or occult blood loss suspected:

    • Upper endoscopy with small bowel biopsy (celiac disease occurs in 2-3% of IDA) 4
    • Colonoscopy (particularly in men and post-menopausal women) 4

Clinical Context Considerations

Age and Sex Matter

  • In men and post-menopausal women: GI blood loss is the most common cause of iron deficiency, requiring endoscopic evaluation 4
  • In pre-menopausal women: Menstrual blood loss is most common, but GI evaluation still warranted if ferritin very low 4

Hemochromatosis Red Flags

  • Family history of liver disease, diabetes, or arthropathy
  • Skin hyperpigmentation
  • Arthralgia (especially metacarpophalangeal joints)
  • Fatigue, weakness
  • Anemia in hemochromatosis is NOT typical and suggests another concurrent process 1

Hypophosphatasia Red Flags

  • Dental problems (premature tooth loss, "gray gums") 8
  • Recurrent stress fractures or pseudofractures 3, 10
  • Chronic musculoskeletal pain (92% of cases) 2
  • Family history of low ALP or bone disease 2
  • ALP ≤25 IU/L has very high predictive value for genetic HPP 10

Management Priorities

Do NOT start bisphosphonates or other antiresorptive therapy until hypophosphatasia is excluded - these are contraindicated in HPP and can worsen outcomes 10.

Do NOT start iron supplementation until ferritin results return - if hemochromatosis is present, iron therapy would be harmful 7.

Do NOT assume dietary deficiency explains the findings - even with positive dietary history, full investigation is required given the severity of abnormalities 4.

The combination of very low ALP with high iron and anemia is unusual and warrants hematology consultation if initial workup does not clarify the diagnosis 9, 5.

Related Questions

In a 61-year-old male with decreasing alkaline phosphatase levels (39, 31, and 29 U/L) over the past nine months, what is the clinical significance and how should this be evaluated?
What is the differential diagnosis and recommended evaluation for a 46-year-old male with persistently low alkaline phosphatase (26–33 U/L)?
In a 73-year-old man with chronically low alkaline phosphatase (31–33 U/L), should this be a cause for concern?
In a 32-year-old man with irritable bowel syndrome (diarrhea subtype) and a negative celiac disease work-up, what is the significance of a low-normal alkaline phosphatase (~45 U/L) and what should be the next step in management?
What does an alkaline phosphatase level of 29, which is below the normal range of 31-129, indicate?
Which specialty manages an anterior mediastinal mass that could represent thymic hyperplasia or thymoma?
What is the most appropriate initial recommendation for a 7-year-old girl with difficulty falling asleep, variable bedtime, irregular sleep locations, occasional night waking, and frequent naps?
For a 78‑year‑old man with depression after a hip fracture who is experiencing anorexia and weight loss, is duloxetine or mirtazapine the more appropriate first‑line treatment?
In a 36-year-old man with two weeks of right-sided back pain and right paraspinal tenderness, what is the most appropriate first-line therapy: meloxicam, lidoderm (capsaicin) patch, or transcutaneous electrical nerve stimulation (TENS)?
Which medication among pitolisant, sodium oxybate, solriamfetol, and modafinil carries the highest risk of prolonging the QT interval and precipitating a malignant cardiac arrhythmia?
How far apart should fluvoxamine doses be taken?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.